Cite

    Chopra, A. et al. (2016). Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study. Clinical rheumatology. 35 (4), pp. 1059-1064. [Online].